Shares of WisdomTree BioRevolution Fund (BATS:WDNA – Get Free Report) were up 27.5% on Friday . The company traded as high as $13.14 and last traded at $16.91. Approximately 465 shares were traded during mid-day trading, a decline of 51% from the average daily volume of 948 shares. The stock had previously closed at $13.26.
WisdomTree BioRevolution Fund Stock Up 27.5%
The business’s fifty day moving average is $14.58 and its two-hundred day moving average is $13.57. The stock has a market capitalization of $2.54 million, a PE ratio of 17.03 and a beta of 1.01.
Institutional Inflows and Outflows
A hedge fund recently raised its stake in WisdomTree BioRevolution Fund stock. Jane Street Group LLC boosted its position in shares of WisdomTree BioRevolution Fund (BATS:WDNA – Free Report) by 45.9% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 16,864 shares of the company’s stock after buying an additional 5,306 shares during the quarter. Jane Street Group LLC owned 11.24% of WisdomTree BioRevolution Fund worth $231,000 as of its most recent filing with the Securities & Exchange Commission.
About WisdomTree BioRevolution Fund
The WisdomTree BioRevolution Fund (WDNA) is an exchange-traded fund that is based on the WisdomTree BioRevolution index. The fund tracks a modified equally-weighted index of companies in developed markets that focus on the advancements in genetics and biotechnology. WDNA was launched on Jun 3, 2021 and is managed by WisdomTree.
Featured Articles
- Five stocks we like better than WisdomTree BioRevolution Fund
- Why Invest in 5G? How to Invest in 5G Stocks
- After Trump Deal, Can Meta Stock Withstand TikTok’s Onslaught?
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Alphabet: After Its Best Quarter in Decades, Is It Time to Buy?
- 3 Best Fintech Stocks for a Portfolio Boost
- Forget Airlines—These Trucking Stocks Are Shifting Into High Gear
Receive News & Ratings for WisdomTree BioRevolution Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WisdomTree BioRevolution Fund and related companies with MarketBeat.com's FREE daily email newsletter.